Lisha Tang

Dysregulation of INF2-mediated mitochondrial fission in SPOP-mutated prostate cancer

Xiaofeng Jin, Jie Wang, Kun Gao et al. · PLoS Genetics · 2017 · 86 citations · Full text

Medicine, Genetics, Oncology +12

In vitro and in vivo characterization of a benzofuran derivative, a potential anticancer agent, as a novel Aurora B kinase inhibitor

Fang Xie, Hengrui Zhu, Haoxing Zhang et al. · European Journal of Medicinal Chemistry · 2014 · 72 citations · Full text

Medicine, Medicinal Chemistry, Oncology +16

Identification of two novel human dynein light chain genes, DNLC2A and DNLC2B, and their expression changes in hepatocellular carcinoma tissues from 68 Chinese patients

Jianming Jiang, Long Yu, Xinghua Huang et al. · Gene · 2001 · 64 citations

Medicine, Molecular Biology, Oncology +10

Reversal of P-gp and MRP1-mediated multidrug resistance by H6, a gypenoside aglycon from Gynostemma pentaphyllum, in vincristine-resistant human oral cancer (KB/VCR) cells

Hengrui Zhu, Zulong Liu, Lisha Tang et al. · European Journal of Pharmacology · 2012 · 48 citations

Medicine, Oncology, Pharmacology +17

Shizukaol D, a Dimeric Sesquiterpene Isolated from Chloranthus serratus, Represses the Growth of Human Liver Cancer Cells by Modulating Wnt Signalling Pathway

Lisha Tang, Hengrui Zhu, Xianmei Yang et al. · PLoS ONE · 2016 · 33 citations · Full text

Medicine, Cancer Biology, Oncology +12